Showing 2711-2720 of 4166 results for "".
- Clearside Biomedical Announces First Patients Enrolled in Phase 1/2a Clinical Trial of CLS-AX for the Treatment of Wet AMDhttps://modernod.com/news/clearside-biomedical-announces-first-patients-enrolled-in-phase-1-2a-clinical-trial-of-cls-ax-for-the-treatment-of-wet-amd/2478744/Clearside Biomedical announced that the first patients have been enrolled in its phase 1/2a clinical trial of CLS-AX (axitinib injectable suspension) in patients with wet age-related macular degeneration (AMD). Clinical sites, all based in the United States, are activated and curr
- Staar Surgical Announces Completion of Patient Enrollment in EVO Implantable Lens US Clinical Trialhttps://modernod.com/news/staar-surgical-announces-completion-of-patient-enrollment-in-evo-implantable-lens-us-clinical-trial/2478275/Staar Surgical has announced that patient enrollment for the primary study analysis cohort of 300 subjects has been achieved in its FDA clinical trial, “A Multicenter Clinical Evaluation of the EVO/EVO+ Visian Implantable Collamer Lens.” Primary study analysis will be conducted when 300 primary e
- Sight Sciences Announces First Patients Enrolled in ORION Clinical Trial of the OMNI Surgical Systemhttps://modernod.com/news/sight-sciences-announces-first-patients-enrolled-in-orion-clinical-trial-of-the-omni-surgical-system/2478138/Sight Sciences announced the enrollment of the first patients in the ORION clinical study. The purpose of the study is to build upon the body of clinical evidence and commercial use of the OMNI Surgical System in pseudophakic eyes by providing ophthalmic surgeons with prospective, multicenter cli
- AAOpt and ASCO Establish Virtual Clinical Training Program to Keep Optometry Students on Graduation Trackhttps://modernod.com/news/aaopt-and-asco-establish-virtual-clinical-training-program-to-keep-optometry-students-on-graduation-track/2477542/With COVID-19 leaving students unable to see patients in person, the American Academy of Optometry (AAO) is establishing an unprecedented virtual clinical training program to help the nation’s 1,800 4th year prospective Doctors of Optometry accumulate the 350 clinical observation hours they need
- Vertex Aims for “Virtual Clinic Visits” to Keep Ongoing Studies on Track Amid COVID-19 Pandemichttps://modernod.com/news/vertex-aims-for-virtual-clinic-visits-to-keep-ongoing-studies-on-track-amid-covid-19-pandemic/2477483/Vertex Pharmaceuticals said that due to the COVID-19 pandemic, the company is working with clinical trial sites to enable “virtual clinic visits” and home delivery of study drugs to ensure that ongoing trials continue as planned with the correct monitoring and procedures in place. How
- Results from First Clinical Study Using Danoprevir to Treat Naive and Experienced COVID-19 Patientshttps://modernod.com/news/results-from-first-clinical-study-using-danoprevir-to-treat-naive-and-experienced-covid-19-patients/2477455/Ascletis Pharma announced the first clinical study using Ganovo (danoprevir) to treat naive and experienced COVID-19 patients was published in medRxiv. The data from this small-sample clinical study showed that danoprevir combined with ritonavir is safe and well tolerated in all p
- Lineage Provides Positive Update on Phase 1/2a Clinical Study of OpRegen for the Treatment of Dry Age-Related Macular Degenerationhttps://modernod.com/news/lineage-provides-positive-update-on-phase-i-iia-clinical-study-of-opregen-for-the-treatment-of-dry-age-related-macular-degeneration/2477278/Lineage Cell Therapeutics a clinical-stage biotechnology company developing novel cellular therapies for unmet medical needs, today provided an update from its ongoing phase 1/2a clinical study of OpRegen, the company’s retinal pigment epithelium (RPE) transplant therapy, for the treatment of dry
- Aerie Pharmaceuticals Announces Appointment of Michelle Senchyna, PhD, as Vice President, Clinical Development and Medical Affairshttps://modernod.com/news/aerie-pharmaceuticals-announces-appointment-of-michelle-senchyna-phd-as-vice-president-clinical-development-and-medical-affairs/2477271/Aerie Pharmaceuticals announced the appointment of Michelle Senchyna, PhD, as Vice President, Clinical Development and Medical Affairs, reporting to David A. Hollander, MD, MBA, Aerie’s Chief Research & Development Officer. Dr. Senchyna will lead and direct the clinical development and
- Genentech/Roche’s Faricimab Phase 3 Program Fully Recruited with Enrollment Completion of Wet AMD Clinical Trialshttps://modernod.com/news/genentech-roches-faricimab-phase-3-program-fully-recruited-with-enrollment-completion-of-wet-amd-clinical-trials/2477161/Genentech and Roche have completed patient enrollment in the TENAYA and LUCERNE phase 3 clinical trials investigating faricimab for the treatment of wet age-related macular degeneration (AMD). The phase 3 YOSEMITE and RHINE diabetic macular edema (DME) clinical trials completed patient enrollment
- Aura Biosciences Announces Updated Phase 1b/2 Clinical Data for AU-011 Presented at AAOhttps://modernod.com/news/aura-biosciences-announces-updated-phase-1b-2-clinical-data-for-au-011-presented-at-aao/2477015/Aura Biosciences announced the presentation of updated clinical data from its ongoing phase 1b/2 clinical trial evaluating the safety and efficacy of light-activated AU-011, the company’s lead product candidate for the first line treatment of primary choroidal melanoma, at the American Academy of